What Happens to Your Body After Stopping Wegovy

The biology behind why weight tends to return

Wegovy (semaglutide 2.4mg) is a GLP-1 receptor agonist. Throughout treatment it slows how quickly the stomach empties, reduces hunger signals reaching the brain, and raises the sense of fullness after eating. These effects are active only while the medicine is present in the body. Semaglutide's half-life means it clears over roughly five to seven weeks after the final dose, and appetite tends to creep back before it has fully gone. Most people notice this within two to four weeks of stopping.

The STEP 1 trial, published in the New England Journal of Medicine, followed participants after the treatment phase ended: within a year of stopping, a substantial proportion of the weight lost had returned, on average. This is not unusual for any appetite-regulating medicine, it reflects the underlying biology of obesity rather than a flaw in the treatment. The NHS patient information on semaglutide notes this directly and recommends discussing a plan for after treatment with your prescriber before you stop.

Understanding this biology matters because it changes how you interpret what you feel in the weeks after your last injection. Increased hunger is expected; it does not mean something has gone wrong. It does mean the window immediately after stopping is when consistent eating habits and activity matter most. A dietitian or structured programme can help bridge this period, your prescriber can advise on referral options.

Whether weight regain after Wegovy is inevitable

The short, honest answer is that regain is common but not universal, and its scale varies considerably between individuals. Factors that appear to reduce regain include the lifestyle changes built during treatment (food habits, portion awareness, regular activity) continuing after the medicine stops. People who used treatment as a period to embed new patterns tend to fare better than those who relied on appetite suppression alone.

There is a useful check you can do in under a minute: scroll back through the last two weeks of meals or activity you logged during treatment. If the habits that reduced your intake were mainly the medicine doing the work rather than changed routines, that is the gap to plan for. If the routines genuinely shifted, those are worth actively protecting after stopping.

The evidence on weight regain after stopping Wegovy is covered in detail on a dedicated page, including what the data says about the timeline and what lifestyle evidence exists for slowing the return. It is also worth knowing that NICE's recommendation for semaglutide (TA875) is that it is used for a maximum of two years within a specialist weight management programme, the time limit exists partly because of this regain question, and the structured support that comes alongside NHS treatment is designed with it in mind. NICE's guidance on semaglutide sets out those criteria in full.

What the decision to stop actually involves

People stop Wegovy for many different reasons: side effects that haven't settled, a planned pregnancy, the cost of long-term private treatment, a feeling that they have reached a stable point, or a clinical recommendation. The right approach differs in each case, and a prescriber who knows your history is the person best placed to help you make it safely.

If you are stopping because of cost, it is worth reading about how Wegovy is priced privately before making a final decision, the full picture sometimes changes things. If you are stopping because you feel you have reached your goal, the question of how long to continue at a maintenance approach is one our clinical team fields regularly; you can see how our prescribers approach clinical decisions if you want to understand the reasoning behind the advice we give.

Stopping in the middle of a dose-titration phase carries the same regain risk as stopping at maintenance; there is no clinical advantage to finishing a particular dose rung before stopping. What matters more is having a plan for the period after, not the timing within the schedule, and our page on stopping Wegovy after weight loss walks through what that planning typically looks like. If pregnancy or trying to conceive is the reason, stopping is the right call, semaglutide is not recommended during pregnancy or while breastfeeding, and a wash-out period before trying to conceive is advised by the MHRA. Your GP is the right first contact in that situation.

Restarting, and what that would involve

Restarting Wegovy after a break is clinically possible. It is not simply a case of picking up where you left off, a new clinical assessment is needed, the original starting dose is typically used again to manage tolerability, and any prescriber (including a private one) should review your current health picture before issuing a new prescription. The practicalities of restarting are worth understanding before you decide to stop, because knowing the restart path is open can reduce the pressure of the decision.

If you stopped after only a short time on treatment, the considerations are somewhat different. The specific situation of stopping very early has its own dynamics, particularly around whether any meaningful physiological effect was established. Either way, the general principle holds: a prescriber should be involved, and the decision should be made with your full health picture in view.

If you are thinking about what comes next and want a clinical opinion, our prescribers can review your situation through a free consultation. Check your eligibility and our team will assess whether continuing, restarting, or an alternative approach makes sense for you.